ridm@nrct.go.th   ระบบคลังข้อมูลงานวิจัยไทย   รายการโปรดที่คุณเลือกไว้

Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure

หน่วยงาน มหาวิทยาลัยเชียงใหม่

รายละเอียด

ชื่อเรื่อง : Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure
นักวิจัย : Jourdain G. , Wagner T.A. , Ngo-Giang-Huong N. , Sirirungsi W. , Klinbuayaem V. , Fregonese F. , Nantasen I. , Techapornroong M. , Halue G. , Nilmanat A. , Wittayapraparat P. , Chalermpolprapa V. , Pathipvanich P. , Yuthavisuthi P. , Frenkel L.M. , Lallemant M.
คำค้น : -
หน่วยงาน : มหาวิทยาลัยเชียงใหม่
ผู้ร่วมงาน : -
ปีพิมพ์ : 2553
อ้างอิง : 10584838 , 10.1086/652148 , 20377404 , CIDIE , http://www.scopus.com/inward/record.url?eid=2-s2.0-77951790626&partnerID=40&md5=c35a39cae10a88460aaf88f658419c29 , http://cmuir.cmu.ac.th/handle/6653943832/863
ที่มา : -
ความเชี่ยวชาญ : -
ความสัมพันธ์ : -
ขอบเขตของเนื้อหา : -
บทคัดย่อ/คำอธิบาย :

Background. Antiretroviral therapy (ART) has become more available throughout the developing world during the past 5 years. The World Health Organization recommends nonnucleoside reverse-transcriptase inhibitor-based regimens as initial ART. However, their efficacy may be compromised by resistance mutations selected by singledose nevirapine (sdNVP) used to prevent mother-to-child transmission of human immunodeficiency virus (HIV)1. There is no simple and efficient method to detect such mutations at the initiation of ART. Methods. One hundred eighty-one women who were participating in a clinical trial to prevent mother-tochild transmission and who started NVP-ART after they had received sdNVP or a placebo were included in the study. One hundred copies of each patient's HIV-1 DNA were tested for NVP-resistance point-mutations (K103N, Y181C, and G 190A) with a sensitive oligonucleotide ligation assay that was able to detect mutants even at low concentrations (≥5% of the viral population). Virologic failure was defined as confirmed plasma HIV-1 RNA >50 copies/mL after 6 to 18 months of NVP-ART. Results. At initiation of NVP-ART, resistance mutations were identified in 38 (26%) of 148 participants given sdNVP (K103N in 19 [13%], Y181C in 8 [5%], G190A in 28 [19%], and ≥2 mutations in 15 [10%]), at a median 9.3 months after receipt of sdNVP. The risk of virologic failure was 0.62 (95% confidence interval [CI], 0.460.77) in women with ≥1 resistance mutation, compared with a risk of 0.25 (95% CI, 0.17-0.35) in those without detectable resistance mutations (P < .001). Failure was independently associated with resistance, an interval of <6 months between sdNVP and NVP-ART initiation, and a viral load higher than the median at NVP-ART initiation. Conclusions. Access to simple and inexpensive assays to detect low concentrations of NVP-resistant HIV-1 DNA before the initiation of ART could help improve the outcome of first-line ART. © 2010 by the Infectious Diseases Society of America. All rights reserved.

บรรณานุกรม :
Jourdain G. , Wagner T.A. , Ngo-Giang-Huong N. , Sirirungsi W. , Klinbuayaem V. , Fregonese F. , Nantasen I. , Techapornroong M. , Halue G. , Nilmanat A. , Wittayapraparat P. , Chalermpolprapa V. , Pathipvanich P. , Yuthavisuthi P. , Frenkel L.M. , Lallemant M. . (2553). Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure.
    เชียงใหม่ : มหาวิทยาลัยเชียงใหม่ .
Jourdain G. , Wagner T.A. , Ngo-Giang-Huong N. , Sirirungsi W. , Klinbuayaem V. , Fregonese F. , Nantasen I. , Techapornroong M. , Halue G. , Nilmanat A. , Wittayapraparat P. , Chalermpolprapa V. , Pathipvanich P. , Yuthavisuthi P. , Frenkel L.M. , Lallemant M. . 2553. "Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure".
    เชียงใหม่ : มหาวิทยาลัยเชียงใหม่ .
Jourdain G. , Wagner T.A. , Ngo-Giang-Huong N. , Sirirungsi W. , Klinbuayaem V. , Fregonese F. , Nantasen I. , Techapornroong M. , Halue G. , Nilmanat A. , Wittayapraparat P. , Chalermpolprapa V. , Pathipvanich P. , Yuthavisuthi P. , Frenkel L.M. , Lallemant M. . "Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure."
    เชียงใหม่ : มหาวิทยาลัยเชียงใหม่ , 2553. Print.
Jourdain G. , Wagner T.A. , Ngo-Giang-Huong N. , Sirirungsi W. , Klinbuayaem V. , Fregonese F. , Nantasen I. , Techapornroong M. , Halue G. , Nilmanat A. , Wittayapraparat P. , Chalermpolprapa V. , Pathipvanich P. , Yuthavisuthi P. , Frenkel L.M. , Lallemant M. . Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure. เชียงใหม่ : มหาวิทยาลัยเชียงใหม่ ; 2553.